Epidemiological studies have suggested that aspirin may have a protective effect against prostate cancer, but the evidence is still limited and inconsistent The role of aspirin in prostate cancer risk was analysed in a multicentric case-control study conducted in Italy between 1991 and 2002, including 1261 incident cases of carcinoma of the prostate and 1131 hospital controls. A total of 115 (9.1%) cases versus 90 (8.0%) controls reported regular aspirin use. The multivariate odds ratio (OR) for regular aspirin users was 1.10 (95% confidence interval (95% CI) 0.81-1.50). No relation was found with duration of use (OR = 1.03 for < 5 years, and 1.17 for >= 5 years) and time since first use (OR = 1.03 for < 10 years, and 1.35 for >= 10 years). These findings do not support a protective role of regular aspirin use on prostate cancer risk.

Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C (2006). Aspirin and the risk of prostate cancer. EUROPEAN JOURNAL OF CANCER PREVENTION, 15(1), 43-45 [10.1097/01.cej.0000180665.04335.de].

Aspirin and the risk of prostate cancer

Negri E;
2006

Abstract

Epidemiological studies have suggested that aspirin may have a protective effect against prostate cancer, but the evidence is still limited and inconsistent The role of aspirin in prostate cancer risk was analysed in a multicentric case-control study conducted in Italy between 1991 and 2002, including 1261 incident cases of carcinoma of the prostate and 1131 hospital controls. A total of 115 (9.1%) cases versus 90 (8.0%) controls reported regular aspirin use. The multivariate odds ratio (OR) for regular aspirin users was 1.10 (95% confidence interval (95% CI) 0.81-1.50). No relation was found with duration of use (OR = 1.03 for < 5 years, and 1.17 for >= 5 years) and time since first use (OR = 1.03 for < 10 years, and 1.35 for >= 10 years). These findings do not support a protective role of regular aspirin use on prostate cancer risk.
2006
Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia C (2006). Aspirin and the risk of prostate cancer. EUROPEAN JOURNAL OF CANCER PREVENTION, 15(1), 43-45 [10.1097/01.cej.0000180665.04335.de].
Bosetti C; Talamini R; Negri E; Franceschi S; Montella M; La Vecchia C
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/867083
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 29
social impact